ArticleMaterials today. Bio2026
Spatiotemporal ultrasound-driven piezoelectric electro-NO therapy restores neuro-vascular-immune homeostasis for radiation ulcer repair.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiation ulcers (RUs) represent a devastating and intractable complication arising from radiotherapy, driven by a self-perpetuating pathological cascade featuring persistent oxidative stress, unresolved chronic inflammation, progressive neurovascular destruction, and recurrent bacterial infection, which cannot be sufficiently mitigated by conventional single-target therapeutic interventions. Both electrical stimulation (ES) and nitric oxide (NO) therapy exhibit promising regenerative potential for tissue repair; nevertheless, traditional ES relies on invasive implanted electrodes with unsatisfactory spatial controllability, whereas exogenous NO delivery suffers from insufficient spatiotemporal precision and potential off-target cytotoxicity. Herein, we developed an injectable collagen hydrogel (CKPB) integrating with potassium sodium niobate nanoparticles loaded with an ultrasound-sensitive NO donor. Upon non-invasive ultrasound triggering, this integrated platform achieves wireless generation of localized electric fields as well as spatiotemporally tunable NO release. In a murine RUs model, CKPB/US treatment efficiently facilitated nerve regeneration, M2 macrophage polarization, angiogenesis, antioxidant defense and antibacterial properties. Such multi-faceted therapeutic effects contribute to the recovery of near-physiological epidermal architecture, improved functional blood perfusion, and strengthened overall tissue integrity. Collectively, this work establishes a noninvasive, dual-modality strategy to reconstruct neuro-vascular-immune homeostasis, offering a rational framework for coordinating multimodal signals to target complex pathological microenvironments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.